A bill for an act imposing a tax on certain products containing nicotine or nonnicotine substances, and including effective date and applicability provisions.(See SF 475, SF 638.)
The revenue generated from these taxes is earmarked for the newly established Iowa Cancer Research Fund, which will support cancer research initiatives within the state. This fund is designed to be distinct from the general fund and will not permit disbursements until after July 1, 2026. The bill mandates that the Department of Health and Human Services (HHS) outlines a procedure for cancer researchers to apply for financing from this fund, potentially aiding in advancing public health and research-focused outcomes in Iowa.
Senate Study Bill 1137 introduces a new tax framework specifically targeting certain nicotine and nonnicotine products, including e-liquids, vaping cartridges, and nicotine pouches. The bill envisions imposing direct taxes on the retail sale of these products, setting the tax rates at $1.15 per vapor cartridge, 6.8 cents per nicotine pouch, and 15% of the retail sales price for products that require e-liquids. It emphasizes that these taxes will be additional to existing state sales taxes, thereby increasing the overall tax burden on consumers of these products.
While the bill aims to further state-level health initiatives and provide funding for critical cancer research, it may generate contention among various stakeholders. Proponents of the bill are likely to advocate for its public health benefits related to reducing nicotine consumption and funding important health research. In contrast, opponents may view the increased taxes as burdensome, particularly for consumers and retailers in the vaping industry. Concerns may also arise regarding the effectiveness of such taxes in altering consumer behavior, as well as the potential negative impacts on local businesses dealing in these products.